Bio-Rad reaffirms 2026 currency-neutral revenue growth at (-3%) to 0.5% while targeting non-GAAP operating margin in upper half of 10% to 12% range
Source: Seeking Alpha ·
Read the full story at Seeking Alpha
Shared from the GodsView world desk: live wires next to a globe of flights, ships, fires, and quakes.